Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia-Pacific artificial intelligence (AI) in drug discovery market will grow by 33.2% over 2020-2026 with a total addressable market cap of $2.78 billion

Asia Pacific artificial intelligence (AI) in drug discovery will grow by 33.2% over 2020-2026 with a total addressable market cap of $2.78 billion owing to fast adoption of AI technology in pharmaceutical industry and drug development. Highlighted with 34 tables and 53 figures, this 121-page report “Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country. Based on offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Software • Service Based on technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Deep Learning • Supervised Learning • Reinforcement Learning • Unsupervised Learning • Other Technologies Based on drug type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Large-molecule Drugs • Small-molecular Drugs Based on therapeutic area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Oncology • Neurodegenerative Diseases • Cardiovascular Disease • Metabolic Diseases • Other Therapeutic Areas Based on application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Information & Data Analysis • Drug Design • Drug Evaluation • Clinical Trials • Other Applications Based on end user, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section. • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Contract Research Organizations Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific AI in drug discovery market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Atomwise, Inc. BenevolentAI Berg LLC Bioage BIOAGE Cloud Pharmaceuticals, Inc. Cyclica Deep Genomics Envisagenics Exscientia Google IBM Corporation Insilico Medicine Microsoft Corporation Numedii, Inc. Numerate NVIDIA Corporation Owkin, Inc. Twoxar, Incorporated Verge Genomics Xtalpi, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 14
  • 1.2.6 Market Size/Share Estimation 15
  • 1.2.7 Research Limitations 16
  • 1.3 Executive Summary 17
  • 2 Market Overview and Dynamics 20
  • 2.1 Market Size and Forecast 20
  • 2.2 Major Growth Drivers 22
  • 2.3 Market Restraints and Challenges 25
  • 2.4 Emerging Opportunities and Market Trends 28
  • 2.5 Porter’s Fiver Forces Analysis 32
  • 3 Segmentation of Asia Pacific Market by Offering 36
  • 3.1 Market Overview by Offering 36
  • 3.2 Software 38
  • 3.3 Service 39
  • 4 Segmentation of Asia Pacific Market by Technology 40
  • 4.1 Market Overview by Technology 40
  • 4.2 Deep Learning 42
  • 4.3 Supervised Learning 43
  • 4.4 Reinforcement Learning 44
  • 4.5 Unsupervised Learning 45
  • 4.6 Other Technologies 46
  • 5 Segmentation of Asia Pacific Market by Drug Type 47
  • 5.1 Market Overview by Drug Type 47
  • 5.2 Large-molecule Drugs 49
  • 5.3 Small-molecular Drugs 50
  • 6 Segmentation of Asia Pacific Market by Therapeutic Area 51
  • 6.1 Market Overview by Therapeutic Area 51
  • 6.2 Oncology 54
  • 6.3 Neurodegenerative Diseases 55
  • 6.4 Cardiovascular Disease 56
  • 6.5 Metabolic Diseases 57
  • 6.6 Other Therapeutic Areas 58
  • 7 Segmentation of Asia Pacific Market by Application 59
  • 7.1 Market Overview by Application 59
  • 7.2 Information & Data Analysis 61
  • 7.3 Drug Design 62
  • 7.4 Drug Evaluation 63
  • 7.5 Clinical Trials 64
  • 7.6 Other Applications 65
  • 8 Segmentation of Asia Pacific Market by End User 66
  • 8.1 Market Overview by End User 66
  • 8.2 Pharmaceutical & Biotechnology Companies 68
  • 8.3 Academic & Research Institutes 69
  • 8.4 Contract Research Organizations 70
  • 9 Asia-Pacific Market 2019-2026 by Country 71
  • 9.1 Overview of Asia-Pacific Market 71
  • 9.2 China 74
  • 9.3 Japan 76
  • 9.4 India 79
  • 9.5 Australia 81
  • 9.6 South Korea 83
  • 9.7 Rest of APAC Region 85
  • 10 Competitive Landscape 87
  • 10.1 Overview of Key Vendors 87
  • 10.2 New Product Launch, Partnership, Investment, and M&A 92
  • 10.3 Company Profiles 93
  • Atomwise, Inc. 93
  • BenevolentAI 95
  • Berg LLC 96
  • Bioage 97
  • BIOAGE 98
  • Cloud Pharmaceuticals, Inc. 99
  • Cyclica 100
  • Deep Genomics 101
  • Envisagenics 102
  • Exscientia 103
  • Google 104
  • IBM Corporation 105
  • Insilico Medicine 106
  • Microsoft Corporation 107
  • Numedii, Inc. 108
  • Numerate 109
  • NVIDIA Corporation 110
  • Owkin, Inc. 111
  • Twoxar, Incorporated 112
  • Verge Genomics 113
  • Xtalpi, Inc. 114
  • 11 Investing in Asia Pacific Market: Risk Assessment and Management 115
  • 11.1 Risk Evaluation of Asia Pacific Market 115
  • 11.2 Critical Success Factors (CSFs) 118
  • Related Reports and Products 121

Table 1. Snapshot of Asia Pacific AI in Drug Discovery Market, 2019-2026 18
Table 2. Main Product Trends and Market Opportunities in Asia Pacific AI in Drug Discovery Market 28
Table 3. Asia Pacific AI in Drug Discovery Market by Offering, 2015-2026, $ mn 36
Table 4. Asia Pacific AI in Drug Discovery Market by Technology, 2015-2026, $ mn 40
Table 5. Asia Pacific AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn 47
Table 6. Asia Pacific AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 51
Table 7. Selected Drug Development Pipelines Aided by AI 53
Table 8. Asia Pacific AI in Drug Discovery Market by Application, 2015-2026, $ mn 59
Table 9. Asia Pacific AI in Drug Discovery Market by End User, 2015-2026, $ mn 66
Table 10. APAC AI in Drug Discovery Market by Country, 2015-2026, $ mn 72
Table 11. China AI in Drug Discovery Market by Technology, 2015-2026, $ mn 75
Table 12. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 75
Table 13. China AI in Drug Discovery Market by End User, 2015-2026, $ mn 75
Table 14. Japan AI in Drug Discovery Market by Technology, 2015-2026, $ mn 78
Table 15. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 78
Table 16. Japan AI in Drug Discovery Market by End User, 2015-2026, $ mn 78
Table 17. India AI in Drug Discovery Market by Technology, 2015-2026, $ mn 80
Table 18. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 80
Table 19. India AI in Drug Discovery Market by End User, 2015-2026, $ mn 80
Table 20. Australia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 82
Table 21. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 82
Table 22. Australia AI in Drug Discovery Market by End User, 2015-2026, $ mn 82
Table 23. South Korea AI in Drug Discovery Market by Technology, 2015-2026, $ mn 84
Table 24. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 84
Table 25. South Korea AI in Drug Discovery Market by End User, 2015-2026, $ mn 84
Table 26. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, $ mn 86
Table 27. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 90
Table 28. Atomwise, Inc.: Company Snapshot 93
Table 29. Atomwise, Inc.: Business Segmentation 93
Table 30. Atomwise, Inc.: Product Portfolio 94
Table 31. Atomwise, Inc.: Revenue, 2016-2018, $ mn 94
Table 32. Atomwise, Inc.: Recent Developments 94
Table 33. Risk Evaluation for Investing in Asia Pacific Market, 2019-2026 116
Table 34. Critical Success Factors and Key Takeaways 119

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 17
Figure 5. Asia Pacific AI in Drug Discovery Market, 2019-2026, $ mn 20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific AI in Drug Discovery Market 22
Figure 7. Primary Restraints and Impact Factors of Asia Pacific AI in Drug Discovery Market 25
Figure 8. Investment Opportunity Analysis 29
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific AI in Drug Discovery Market 32
Figure 10. Breakdown of Asia Pacific AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 36
Figure 11. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%) 37
Figure 12. Asia Pacific AI in Drug Discovery Market: Software, 2015-2026, $ mn 38
Figure 13. Asia Pacific AI in Drug Discovery Market: Service, 2015-2026, $ mn 39
Figure 14. Breakdown of Asia Pacific AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 40
Figure 15. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%) 41
Figure 16. Asia Pacific AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn 42
Figure 17. Asia Pacific AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn 43
Figure 18. Asia Pacific AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn 44
Figure 19. Asia Pacific AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn 45
Figure 20. Asia Pacific AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn 46
Figure 21. Breakdown of Asia Pacific AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 47
Figure 22. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%) 48
Figure 23. Asia Pacific AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn 49
Figure 24. Asia Pacific AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn 50
Figure 25. Breakdown of Asia Pacific AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 51
Figure 26. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%) 52
Figure 27. Asia Pacific AI in Drug Discovery Market: Oncology, 2015-2026, $ mn 54
Figure 28. Asia Pacific AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn 55
Figure 29. Asia Pacific AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn 56
Figure 30. Asia Pacific AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn 57
Figure 31. Asia Pacific AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn 58
Figure 32. Breakdown of Asia Pacific AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 59
Figure 33. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 60
Figure 34. Asia Pacific AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn 61
Figure 35. Asia Pacific AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn 62
Figure 36. Asia Pacific AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn 63
Figure 37. Asia Pacific AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn 64
Figure 38. Asia Pacific AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn 65
Figure 39. Breakdown of Asia Pacific AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 66
Figure 40. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 67
Figure 41. Asia Pacific AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn 68
Figure 42. Asia Pacific AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn 69
Figure 43. Asia Pacific AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn 70
Figure 44. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 72
Figure 45. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 73
Figure 46. AI in Drug Discovery Market in China, 2015-2026, $ mn 74
Figure 47. AI in Drug Discovery Market in Japan, 2015-2026, $ mn 77
Figure 48. AI in Drug Discovery Market in India, 2015-2026, $ mn 79
Figure 49. AI in Drug Discovery Market in Australia, 2015-2026, $ mn 81
Figure 50. AI in Drug Discovery Market in South Korea, 2015-2026, $ mn 83
Figure 51. AI in Drug Discovery Market in Rest of APAC, 2015-2026, $ mn 85
Figure 52. Growth Stage of Asia Pacific AI in Drug Discovery Industry over the Forecast Period 87
Figure 53. Share of Developments of Key Vendors by Strategy Type, 2015-2019 89

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

We are friendly and approachable, give us a call.